Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
sirolimus (rapamune) (1 trial)
Birt-Hogg-Dube Syndrome (Phase 3)
Syndrome (Phase 3)
Trials (1 total)
Trial APIs (1 total)